See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2026_ANI_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 753,117,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 542,006,000 |
| 2 | PropertyPlantAndEquipmentNet | 62,476,000 |
| 3 | remainder_Assets | 82,778,000 |
| 4 | LiabilitiesCurrent | 278,112,000 |
| 5 | LiabilitiesNoncurrent | 304,004,000 |
| 6 | remainder_Liabilities | 317,537,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 657,496,290 |
| 9 | ResearchAndDevelopmentExpense | 50,823,688 |
| 10 | remainder_Expenses | 846,082,745 |
| 11 | remainder_Revenues | 2,227,012,196 |
| 12 | remainder_NetIncome | -13,385,543 |
| 13 | remainder_ComprehensiveNetIncome | -4,262,013 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,440,377,000 |
| 1 | Liabilities | 899,653,000 |
| 2 | Expenses | 1,554,402,723 |
| 3 | Revenues | 2,227,012,196 |
| 4 | StockholdersEquity | 540,724,000 |
| 5 | NetIncome | 659,223,930 |
| 6 | ComprehensiveNetIncome | 657,092,924 |
| 7 | BaseVar | 3,069,546,238 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.57 |
| 9 | EconomicCapitalRatio | 2.73 |
Edgar->Model Mapping
Feature Distribution
Change over Time
